SAB4200869
Anti-Burkholderia pyrrocinia (Pseudomonas pyrrocinia) antibody produced in rabbit
IgG fraction of antiserum
Synonym(s):
Burkholderia pyrrocinia, Pseudomonas pyrrocinia
Sign Into View Organizational & Contract Pricing
Select a Size
About This Item
UNSPSC Code:
12352203
NACRES:
NA.41
Quality Level
form
liquid
species reactivity
(Burkholderia (Pseudomonas)pyrrocinia)
concentration
~1 mg/mL
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
General description
Burkholderia pyrrocinia (previously also known as Burkholderia Pseudomonas) ) belongs to the Burkholderia cepacia complex (Bcc). Burkholderia cepacia complex is a group of at least 20 gram negative bacterial species that are widely distributed in the natural environment such as, soil and water.1 These bacteria have unusually large genomes (7.5-8.5 Mb).2 B. cepacia are opportunistic and nosocomial pathogens that affect mostly immunocompromised individuals such as cystic fibrosis (CF) patients and cause respiratory illness and chronic inflammation.3First, the bacterium initiates primary infection in the respiratory mucosa followed by spreading to adjacent organs and establishing the “cepacia syndrome.
Application
The antibody may be used in various immunochemical techniques including Immunoblotting. Detection of the Burkholderia pyrrocinia bands by Immunoblotting is specifically inhibited by the immunogen.
Biochem/physiol Actions
B. cepacia has the ability to survive intracellularly in alveolar phagocytes and respiratory epithelial cells.8 Moreover, B. cepacia produces quorum sensing (QS) molecules that control virulence factor expression and biofilm formation that shields the bacteria from immune response and antibiotic treatment.1 Bcc are resistant to various types of antibiotics such as, quinolones, aminoglycosides and ß-lactams.1
Anti-Burkholderia pyrrocinia antibody recognizes B. pyrrocinia lysate and whole dead bacteria.
Physical form
Supplied as a solution in 0.01 M phosphate buffered saline pH 7.4, containing 15 mM sodium azide as a preservative.
Preparation Note
For continuous use, store at 2-8°C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not used within 12 hours.
Disclaimer
Unless otherwise stated in our catalog our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
常规特殊物品
This item has
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Virulence factors of Burkholderia cepacia.
J W Nelson et al.
FEMS immunology and medical microbiology, 8(2), 89-97 (1994-02-01)
Tippamas Chuaygud et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 102 Suppl 1, S140-S144 (2009-01-16)
Burkholderia pseudomallei is an agent of melioidosis and is closely related to avirulent B. thailandensis. Burkholderia thailandensis has a 15-bp deletion within the variable region of the flagellin gene fliC compared with B. pseudomallei. The difference in the fliC gene
J L Burns et al.
Infection and immunity, 64(10), 4054-4059 (1996-10-01)
Pulmonary infections caused by Burkholderia (Pseudomonas) cepacia are an important cause of morbidity and mortality in cystic fibrosis (CF) patients. Several features suggestive of cellular invasion and intracellular sequestration of B. cepacia in CF are persistence of infection in the
V Gautam et al.
Indian journal of medical microbiology, 29(1), 4-12 (2011-02-10)
Burkholderia cepacia complex (BCC) is an important nosocomial pathogen in hospitalised patients, particularly those with prior broad-spectrum antibacterial therapy. BCC causes infections that include bacteraemia, urinary tract infection, septic arthritis, peritonitis and respiratory tract infection. Due to high intrinsic resistance
Birgit Huber et al.
Microbiology (Reading, England), 147(Pt 9), 2517-2528 (2001-09-06)
Burkholderia cepacia and Pseudomonas aeruginosa often co-exist as mixed biofilms in the lungs of patients suffering from cystic fibrosis (CF). Here, the isolation of random mini-Tn5 insertion mutants of B. cepacia H111 defective in biofilm formation on an abiotic surface
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service